Michael H. Farkas PhD

Michael Farkas

Michael H. Farkas
PhD

Associate Professor

Department of Ophthalmology

Jacobs School of Medicine & Biomedical Sciences


Specialty/Research Focus

Bioinformatics; Eukaryotic Pathogenesis; Gene Expression; Gene Therapy; Genomics and proteomics; Molecular and Cellular Biology; Molecular Basis of Disease; Molecular genetics; RNA; Stem Cells; Vision science

Contact Information
3495 Bailey Avenue
Bldg 20, Rm 239
Mail Stop 151
Buffalo, New York 14215
Phone: 716-834-9200 x5638
Fax: 716-862-6526
mhfarkas@buffalo.edu



Education and Training:

  • Fellowship, Ophthalmology, Harvard Medical School (2014)
  • Fellowship, Ophthalmology, University of Pennsylvania (2011)
  • PhD, Biological Sciences, State University of New York at Buffalo (2009)
  • MS, Biotechnology, Johns Hopkins University (2004)
  • BS, Biology, University of Pittsburgh at Johnstown, Magna Cum Laude (2002)

Employment:

  • Associate Professor, Ophthalmology, State University of New York at Buffalo (2023-present)
  • Adjunct Assistant Professor, Biochemistry, State University of New York Jacobs School of Medicine & Biomedical Sciences (2017-present)
  • Assistant Professor, Ophthalmology, State University of New York at Buffalo Jacobs School of Medicine & Biomedical Sciences (2016–2023)
  • Instructor, Ophthalmology, Harvard Medical School (2014–2016)
  • Investigator, Ophthalmology, Massachusetts Eye and Ear Infirmary (2014–2016)

Awards and Honors:

  • Emerging Vision Scientist (2016)
  • Ruth L. Kirschstein National Research Service Award (2010)
  • Biological Sciences Fellow (2004)
  • Presidential Fellow (2004)

Research Centers:

  • Ira G. Ross Eye Institute Research Center

UB 2020 Strategic Strengths:

  • Molecular Recognition in Biological Systems and Bioinformatics

Grants and Sponsored Research:

  • October 2019–September 2023
    Epigenetic-guided studies of AMD pathology and iPSC-RPE transplantation therapy
    Department of Veterans Affairs
    Role: Principal Investigator
  • July 2019–September 2021
    Defining the functional role of RPE-expressed AMD risk-associated long non-coding RNAs
    BrightFocus Foundation
    Role: Principal Investigator
  • November 2020–August 2021
    Equipment grant for a human donor iPSC repository
    Carl Marshall Reeves & Mildred Almen Reeves Foundation
    Role: Co-Principal Investigator
  • June 2015–May 2017
    Functional characterization of a novel splice variant in PRPF31
    Foundation Fighting Blindness
    Role: Principal Investigator
    $154,446
  • April 2010–March 2013
    The role of RNA splicing factors in retinal degeneration
    National Eye Institute
    Role: Principal Investigator
    $151,086

Patents:

  • Gene augmentation therapies for inherited retinal degeneration caused by mutations in the PRPF31 gene (2020)

Journal Articles:

See all (15 more)

Books and Book Chapters:

  • Farkas M. (2014) Retinal Disorders: Genetic Approaches to Diagnosis & Treatment. In: Interrogating the transcriptome to study inherited retinal degenerations. Cold Spring Harbor Perspectives
  • Farkas M. (2009) In: Characterization of Chlortetracycline-induced Glutathione S-Transferase to Conjugate Chloroacetanilide and Chlorotriazine Herbicides. ACS Symposium Series
  • Farkas M. (2008) In: Antibiotic transformation in plants via gluthathione conjugation. CRC Press

Professional Memberships:

  • International Society for Eye Research (2023–present)
  • American Society for Human Genetics (2013–present)
  • Association for Research in Vision and Ophthalmology (2010–present)
  • Society for Environmental Toxicology and Chemistry (2005–2009)
  • American Chemical Society (2005–2009)

Presentations:

  • "Building the case for lncRNA involvement in AMD pathophysiology" Duke Ophthalmology Seminar Series (2023)
  • "Epigenetic memory in iPSC differentiation" International Society for Eye Research (2023)
  • "An AMD-associated lncRNA: functional or just deadly?" Ohio State University Department of Ophthalmology (2022)
  • "Envisioning a new pathophysiological mechanism for AMD onset" University of Pennsylvania, F.M. Kirby Center for Molecular Ophthalmology (2022)
  • "Envisioning a new pathophysiological mechanism for AMD onset" University at Buffalo Program for Neuroscience Seminar Series (2022)
  • "Exploring lncRNA dysregulation in AMD pathogenesis" Departmental Seminar Series, Flaum Eye Institute, University of Rochester (2021)
  • "Identification and characterization of a novel lncRNA as a potential biomarker for AMD staging" Departmental Seminar Series, Department of Ophthalmology, SUNY Downstate (2020)
  • "Inherited retinal dystrophies: bridging the mutation to therapy gap using iPS disease modeling" Seminar Series; Childrenā€˜s Hospital Los Angeles (2016)
  • "RNA-Seq guided gene therapy for vision loss" Festival of Genomics (2016)
  • "Targeted capture for RNA-Seq studies" Festival of Genomics (2016)
  • "RNA splicing factor-associated RP: from genetics to gene therapy" Seminar Series; Massachusetts Eye and Ear Infirmary; Ocular Regenerative Medicine Institute (2016)
  • "Insights into the pathogenesis of RNA splicing factor retinitis pigmentosa" Seminar Series; Cincinnati Children's Hospital; Visual Sciences Group (2015)
  • "Insights into the pathogenesis of RNA splicing factor retinitis pigmentosa" Seminar Series; State University of New York at Buffalo; Department of Ophthalmology (2015)
  • "Insights into the pathogenesis of RNA splicing factor retinitis pigmentosa" Seminar Series; Schepens Eye Research Institute; Genetic and Regenerative Medicine of Eye Disease Symposium (2015)
  • "Genetics of and Gene Therapy for Inherited Retinal Degenerations" Program in Medical and Population Genetics; Broad Institute of MIT and Harvard (2014)
  • "RNA-Seq" Illumina Users Group Meeting; Illumina (2013)
  • "Preparation of High Quality RNA-Seq Libraries for Next-Generation sequencing" Webinar; Agilent; Agilent Users Group Meeting (2013)
  • "The Role of Alternative Splicing in the Pathogenesis of RNA Splicing Factor Retinitis Pigmentosa" Seminar Series; State University of New York at Buffalo; Department of Biological Sciences (2013)
  • "Insights into RNA Splicing Factor RP Through Functional Studies and Transcriptome Analyses" Retina Focus Group; Massachusetts Eye and Ear Infirmary; Department of Ophthalmology (2013)
  • "Revealing the Retinal Transcriptome with Next-Generation Sequencing and its Implications for Disease" Illumina Technology Day; Illumina (2012)
  • "Comprehensive Characterization of the Wild-type Mouse Neural Retina Transcriptome Using Next-Generation Sequencing" Seminar Series; University of Pennsylvania; Department of Genetics (2011)
  • "Characterizing the Transcriptomes of RNA Splicing Factor mice" Seminar Series; University of Pennsylvania; F.M. Kirby Center for Molecular Ophthalmology (2010)
See all (12 more)

Service Activities:

  • ZEY1 VSN(03); Ad Hoc Member (2023–present)
  • ZRG1 MGG-V (50); Ad hoc Member (2023–present)
  • BIVT study Section; Ad hoc member (2023–present)
  • Translational Vision and Science Technology (2021–present)
  • Moorfields Eye Hospital, Graduate Student Fellowship in Vision Research (2021–present)
  • Buffalo Chapter of the Society for Neuroscience; President (2021–2022)
  • (2021–present)
  • Molecular Therapy (2021–present)
  • UB Neuroscience Research Day (2021–present)
  • NIH Study Section Special Emphasis Panel, NEI Vision Imaging, Bioengineering and Low Vision Technology Development, ZRG1-ETTN-P (81) S (2021–present)
  • European Journal of Molecular Genetics (2021–present)
  • Faculty and Graduate Professional Research Continuity Committee (2020)
  • Exploration in Medicine (2019–present)
  • Frontiers in Molecular Neuroscience (2019–present)
  • Contingent Employment Committee, United University Professions, Statewide Member (2019–present)
  • Officer for Contingent Employees, UUP; Officer (2019–present)
  • Faculty Council (2019–2021)
  • Online Education Advisory Committee, United University Professions, Statewide Member (2019–present)
  • Data in Brief (2018–present)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

3495 Bailey Avenue
Bldg 20, Rm 239
Mail Stop 151
Buffalo, New York 14215
Phone: 716-834-9200 x5638
Fax: 716-862-6526
mhfarkas@buffalo.edu